Hepatitis B treatment in resource poor settings: time for action.
Chronic hepatitis B virus infection is common cause of morbidity and mortality in resource poor settings. Now that effective drugs are available, international action is needed to implement treatment programmes.
Mark
M
Thursz
Graham S
GS
Cooke
Andrew J
AJ
Hall
D000998:Antiviral Agents / Q000627:therapeutic use*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D007391:International Cooperation; D008507:Medically Underserved Area
D000998:Antiviral Agents